Menopause is one day. Everything else has a different name, a different hormonal signature, and a different set of things worth doing. Here is the whole arc, laid out.
An FDA advisory panel voted against its own agency scientists and recommended six peptides for compounding. It was genuinely remarkable. It also changed nothing about what is legal today, and that gap is where people are getting confused.
A woman with no history of anxiety develops it at 44 and is told she is stressed. There is a receptor-level explanation, and it deserves to be part of the conversation before a prescription is.
Two women with identical symptoms can need opposite things. That is why generic hormone advice fails so reliably — and why I started sorting patterns instead.
You're eating well, exercising consistently, and still the scale won't budge. Before you blame willpower, consider the hormonal drivers of weight loss resistance most doctors never test.
One acts on a single receptor, the other on two. The head-to-head trial produced a clear winner on weight — and a finding about women specifically that most coverage skipped entirely.
Hot flashes and irregular cycles get all the attention — but perimenopause can begin years earlier with symptoms most women (and their doctors) never connect to hormones. Here's what to watch for and when to act.
Unlike almost everything else on this menu, this one has a genuine FDA approval for a women's health condition. The catch is which women the approval covers — and it may not be the ones asking.
Fatigue, weight gain, hair loss, cold intolerance, brain fog — these symptoms point to both thyroid dysfunction and hormonal imbalance. Conventional medicine often tests one and misses the other. Functional medicine tests both — and looks at how they interact.
It is the one growth hormone peptide that was once an approved drug. That history is the most interesting thing about it, and the most useful context for deciding whether it belongs in your plan.
Most longevity peptides have thin human evidence. This one is different — it has been through real clinical trials under the name elamipretide. Here is what that research actually studied, and what it did not.
Standard lab ranges answer a different question than the one you're asking. Here's what 'normal' actually means and which markers deserve a closer look.
Brain fog and anxiety that arrive in your forties are not a personality change. They have a physiology, and it is usually hormonal — which is where any conversation about nootropic peptides has to start.
This is the one compound on the peptide menu where the topical version has better human evidence than the injection. That is worth knowing before you choose.
Most peptides in this category are investigational. This one is an approved drug — though not for the reason most people are asking about it. The distinction is worth understanding.
Joint pain that arrived out of nowhere. Workouts you can't bounce back from. Here's what the research actually shows about the two peptides behind the "Wolverine" protocol — and the hormonal context most articles leave out.
Your thymus starts shrinking in adolescence and is largely fatty tissue by midlife. This peptide comes from what that gland used to produce — and the autoimmune caution matters more than most articles admit.
The most dramatic skin changes of a woman's life aren't a skincare failure — they're an estrogen story. Where the copper peptide GHK-Cu fits, and what it can't fix on its own.
It is one of the few peptides your own mitochondria produce. Researchers have called it an exercise mimetic — a description worth unpacking carefully, because it is both the most interesting and most misused thing said about it.
Some women come in with a gut problem. Some with a skin problem. A surprising number have both — and no one has connected the two for them. The gut–skin axis, explained.
It is genuinely one of the most important molecules your body makes. That is exactly why the marketing around injecting it deserves a careful, skeptical read.
The medication works. The question no one asks loudly enough is what you lose alongside the fat — and in midlife, that question has a much sharper answer than it does at thirty.
It is marketed as the closest thing to a telomere drug. The research base is real but narrow, and mostly published in one country over several decades. Here is what that actually means for a woman considering it.
It hits two receptors instead of one, and the head-to-head trial found women responded even more strongly than men. That difference is worth understanding — along with a contraception interaction most women are never told about.